Michel LS - Search Results

1

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.

Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, Spies NC, Lin T, Li T, Mulder DT, Hanna Y, Cirlan I, Pugh TJ, Mudianto T, Riley R, Zhou L, Jo VY, Stachler MD, Hanna GJ, Kass J, Haddad R, Schoenfeld JD, Gjini E, Lako A, Thorstad W, Gay HA, Daly M, Rodig SJ, Hagemann IS, Kallogjeri D, Piccirillo JF, Chernock RD, Griffith M, Griffith OL, Adkins DR. Uppaluri R, et al. Among authors: michel ls. Clin Cancer Res. 2020 Oct 1;26(19):5140-5152. doi: 10.1158/1078-0432.CCR-20-1695. Epub 2020 Jul 14. Clin Cancer Res. 2020. PMID: 32665297 Free PMC article. Clinical Trial.

2

Cisplatin versus cetuximab given concurrently with definitive radiation therapy for locally advanced head and neck squamous cell carcinoma.

Ley J, Mehan P, Wildes TM, Thorstad W, Gay HA, Michel L, Nussenbaum B, Trinkaus K, Adkins D. Ley J, et al. Oncology. 2013;85(5):290-6. doi: 10.1159/000355194. Epub 2013 Nov 6. Oncology. 2013. PMID: 24217231 Free PMC article.

3

Risk factors for and pre-medications to prevent cetuximab-induced infusion reactions in patients with squamous cell carcinoma of the head and neck.

Touma W, Koro SS, Ley J, Wildes TM, Michel L, Tao Y, Adkins D. Touma W, et al. Oral Oncol. 2014 Sep;50(9):895-900. doi: 10.1016/j.oraloncology.2014.06.017. Epub 2014 Jul 15. Oral Oncol. 2014. PMID: 25037161 Free PMC article.

4

A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck.

Adkins D, Ley J, Dehdashti F, Siegel MJ, Wildes TM, Michel L, Trinkaus K, Siegel BA. Adkins D, et al. Cancer Med. 2014 Dec;3(6):1493-501. doi: 10.1002/cam4.294. Epub 2014 Aug 1. Cancer Med. 2014. PMID: 25081631 Free PMC article. Clinical Trial.

5

Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.

Zhang K, Jones L, Lim S, Maher CA, Adkins D, Lewis J, Kimple RJ, Fertig EJ, Chung CH, Van Tine BA, Ellis MJ, Herrlich A, Michel LS. Zhang K, et al. Among authors: michel ls. Oncotarget. 2014 Oct 15;5(19):9281-94. doi: 10.18632/oncotarget.2423. Oncotarget. 2014. PMID: 25238142 Free PMC article.

6

Looking beyond the CRT paradigm: why induction chemotherapy is worthy of pursuit.

Adkins D, Ley J, Michel L, Wildes TM, Thorstad W, Rich J, Nussenbaum B. Adkins D, et al. Oral Oncol. 2015 Feb;51(2):103-4. doi: 10.1016/j.oraloncology.2014.11.018. Epub 2014 Dec 11. Oral Oncol. 2015. PMID: 25497105 No abstract available.

7

Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck.

Watson RF, Chernock RD, Zhang KH, Michel LS, Adkins DR, El-Mofty SK, Lewis JS Jr. Watson RF, et al. Among authors: michel ls. Head Neck Pathol. 2015 Sep;9(3):360-8. doi: 10.1007/s12105-014-0604-y. Epub 2015 Jan 7. Head Neck Pathol. 2015. PMID: 25563452 Free PMC article.

8

Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck.

Schell A, Ley J, Wu N, Trinkaus K, Wildes TM, Michel L, Thorstad W, Gay H, Lewis J, Rich J, Diaz J, Paniello RC, Nussenbaum B, Adkins DR. Schell A, et al. Cancer Med. 2015 Apr;4(4):481-9. doi: 10.1002/cam4.382. Epub 2015 Jan 26. Cancer Med. 2015. PMID: 25619559 Free PMC article. Clinical Trial.

9

RTOG 0522: huge Investment in patients and resources and no benefit with addition of cetuximab to radiotherapy--why did this occur?

Adkins D, Ley J, Wildes TM, Michel L. Adkins D, et al. J Clin Oncol. 2015 Apr 1;33(10):1223-4. doi: 10.1200/JCO.2014.59.6908. Epub 2015 Feb 23. J Clin Oncol. 2015. PMID: 25713440 No abstract available.

10

Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.

Zenga J, Wilson M, Adkins DR, Gay HA, Haughey BH, Kallogjeri D, Michel LS, Paniello RC, Rich JT, Thorstad WL, Nussenbaum B. Zenga J, et al. Among authors: michel ls. JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1118-27. doi: 10.1001/jamaoto.2015.0764. JAMA Otolaryngol Head Neck Surg. 2015. PMID: 25902372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page